The global Reverse Transcriptase Enzymes Market is projected to grow from USD 370.3 million in 2025 to USD 517.4 million by 2035, reflecting a compound annual growth rate (CAGR) of 3.4% over the ...

Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced the launch of its Codex® HiTemp Reverse Transcriptase for use in one ...

Ultrarapid detection of SARS-CoV-2 RNA using a reverse transcription–free exponential amplification reaction, RTF-EXPAR. Proceedings of the National Academy of Sciences, 2021; 118 (35 ...

The virus that causes COVID-19, SARS-CoV-2, rarely appeared in the conjunctiva when tested by reverse transcriptase-polymerase chain reaction, according to a meta-analysis published in Optometry ...

Since the emergence of COVID-19 in late 2019, the gold standard in testing for the disease has been a nuclear-derived technique: real-time reverse transcription–polymerase chain reaction, or real-time ...

Reverse-Transcriptase PCR (RT-PCR) Reverse transcriptase was discovered in 1970 by Howard Temin (University of Wisconsin–Madison, WI, USA) and David Baltimore (Salk Institute in La Jolla, CA, USA) [6] ...

Reverse Transcriptases Commonly Used for RT-PCR Reverse transcriptase-PCR (RT-PCR)--a method for assessing gene expression, detecting low copy number mRNA transcripts, and generating complementary ...

Studies will need to validate, in a new patient cohort, the prognostic utility of GUCY2C qRT-PCR for categorical identification (yes/no) of occult metastases as a marker of disease recurrence ...

New England Biolabs (NEB®) announced today that they have released a novel, thermostable reverse transcriptase, WarmStart® RTx Reverse Transcriptase, specifically designed for nucleic acid detection.